secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001638833-25-000089
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q1 revenue up 8.2% to $776M; Adj EBITDA $103.9M (+6.6%); net loss $37.7M
--------------------------------------------------------------------------------

- Same-facility revenue +5.2%, same-facility cases +6.5% YoY; revenue per case -1.2%.
- Net loss attributable to Surgery Partners $37.7M; no GAAP EPS provided.
- Adjusted EBITDA $103.9M vs. $97.5M in prior-year quarter (+6.6%).
- Full-year 2025 guidance reaffirmed: revenue $3.30-$3.45B, Adj EBITDA $555-$565M.
- Cash $229.3M + $388.9M revolver capacity; net debt/EBITDA ~4.1x; operating cash flow $6.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883325000089/0001638833-25-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883325000089/sgry-20250512.htm
  HTML page:      https://secwatch.observer/filing/0001638833-25-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer